|
US4666829A
(en)
|
1985-05-15 |
1987-05-19 |
University Of California |
Polypeptide marker for Alzheimer's disease and its use for diagnosis
|
|
US5525339A
(en)
|
1986-08-27 |
1996-06-11 |
Dms Pharmaceutical Inc. |
Isolated components of dense microspheres derived from mammalian brain tissue and antibodies thereto
|
|
US5231170A
(en)
|
1986-08-27 |
1993-07-27 |
Paul Averback |
Antibodies to dense microspheres
|
|
DE3702789A1
(de)
|
1987-01-30 |
1988-08-18 |
Bayer Ag |
Vorlaeuferprotein des apc-polypeptids, dafuer codierende dna und diagnostische verwendung der dna und des proteins
|
|
IT1217123B
(it)
|
1987-02-05 |
1990-03-14 |
Rotta Research Lab |
Derivati otticamente attivi dell acido 5 pentilammino 5 oxo pentanoico r ad attivita antagonista della colecistochinina e procedimento per la loro preparazione
|
|
DE3805744C2
(de)
|
1987-03-04 |
1999-09-23 |
Novartis Ag |
Phenylcarbamate zur Hemmung der Acetylcholinesterase
|
|
AU600575B2
(en)
*
|
1987-03-18 |
1990-08-16 |
Sb2, Inc. |
Altered antibodies
|
|
US5132405A
(en)
|
1987-05-21 |
1992-07-21 |
Creative Biomolecules, Inc. |
Biosynthetic antibody binding sites
|
|
US5091513A
(en)
|
1987-05-21 |
1992-02-25 |
Creative Biomolecules, Inc. |
Biosynthetic antibody binding sites
|
|
FI95572C
(fi)
|
1987-06-22 |
1996-02-26 |
Eisai Co Ltd |
Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi
|
|
JPS6412935A
(en)
|
1987-07-02 |
1989-01-17 |
Mitsubishi Electric Corp |
Constant-speed travel device for vehicle
|
|
CA1340802C
(en)
|
1987-08-15 |
1999-10-26 |
Yasuyuki Takahashi |
Senile amyloid precursor protein and an antibody specific for the same
|
|
US5004697A
(en)
|
1987-08-17 |
1991-04-02 |
Univ. Of Ca |
Cationized antibodies for delivery through the blood-brain barrier
|
|
US5231000A
(en)
|
1987-10-08 |
1993-07-27 |
The Mclean Hospital |
Antibodies to A4 amyloid peptide
|
|
US5843708A
(en)
|
1988-01-05 |
1998-12-01 |
Ciba-Geigy Corporation |
Chimeric antibodies
|
|
AU3204689A
(en)
|
1988-02-10 |
1989-09-06 |
Children's Medical Center Corporation |
Amyloid protein precursors, genetic probes, antibodies, and methods of use
|
|
US6287793B1
(en)
|
1988-08-19 |
2001-09-11 |
Elan Pharmaceuticals, Inc. |
Diagnostic methods for alzheimer's disease
|
|
US5215889A
(en)
|
1988-11-18 |
1993-06-01 |
The Regents Of The University Of California |
Catalytic and reactive polypeptides and methods for their preparation and use
|
|
US20040049014A1
(en)
|
1988-12-28 |
2004-03-11 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US5262332A
(en)
|
1989-04-05 |
1993-11-16 |
Brigham And Women's Hospital |
Diagnostic method for Alzheimer's disease: examination of non-neural tissue
|
|
US5234814A
(en)
|
1989-06-01 |
1993-08-10 |
Du Pont Merck Pharmaceutical Company |
Diagnostic assay for alzheimer's disease
|
|
US5268164A
(en)
|
1990-04-23 |
1993-12-07 |
Alkermes, Inc. |
Increasing blood-brain barrier permeability with permeabilizer peptides
|
|
US5112596A
(en)
|
1990-04-23 |
1992-05-12 |
Alkermes, Inc. |
Method for increasing blood-brain barrier permeability by administering a bradykinin agonist of blood-brain barrier permeability
|
|
US5565332A
(en)
|
1991-09-23 |
1996-10-15 |
Medical Research Council |
Production of chimeric antibodies - a combinatorial approach
|
|
DE69227380T3
(de)
|
1991-11-12 |
2007-01-11 |
Prana Biotechnology Ltd., South Melbourne |
Verfahren zur bestimmung und behandlung von alzheimer-krankheit
|
|
US5811517A
(en)
*
|
1992-01-27 |
1998-09-22 |
Icos Corporation |
ICAM-related protein variants
|
|
US20010029293A1
(en)
*
|
1992-01-27 |
2001-10-11 |
Icos Corporation |
Icam-related protein
|
|
US5837822A
(en)
|
1992-01-27 |
1998-11-17 |
Icos Corporation |
Humanized antibodies specific for ICAM related protein
|
|
US5538845A
(en)
|
1992-02-05 |
1996-07-23 |
Athena Neurosciences, Inc. |
Beta-amyloid peptide production inhibitors and methods for their identification
|
|
US5604102A
(en)
|
1992-04-15 |
1997-02-18 |
Athena Neurosciences, Inc. |
Methods of screening for β-amyloid peptide production inhibitors
|
|
US5441870A
(en)
|
1992-04-15 |
1995-08-15 |
Athena Neurosciences, Inc. |
Methods for monitoring cellular processing of β-amyloid precursor protein
|
|
US5766846A
(en)
|
1992-07-10 |
1998-06-16 |
Athena Neurosciences |
Methods of screening for compounds which inhibit soluble β-amyloid peptide production
|
|
US5837672A
(en)
|
1992-07-10 |
1998-11-17 |
Athena Neurosciences, Inc. |
Methods and compositions for the detection of soluble β-amyloid peptide
|
|
US6610493B1
(en)
|
1993-06-17 |
2003-08-26 |
Brigham And Women's Hospital |
Screening compounds for the ability to alter the production of amyloid-β peptide
|
|
DE69328430T2
(de)
|
1992-07-27 |
2001-01-25 |
The Government Of The United States Of America As Represented By The Secretary Of National Institute Of Health, Office Of Technology Transfer |
Zielgerichte liposome zur blut-hirne schranke
|
|
US5639641A
(en)
|
1992-09-09 |
1997-06-17 |
Immunogen Inc. |
Resurfacing of rodent antibodies
|
|
US5605811A
(en)
|
1992-10-26 |
1997-02-25 |
Athena Neurosciences, Inc. |
Methods and compositions for monitoring cellular processing of beta-amyloid precursor protein
|
|
US5891623A
(en)
|
1992-11-09 |
1999-04-06 |
Consorzio Per Le Biotecnologie |
Diagnosis and treatment of AIDS onset
|
|
ZA938243B
(en)
|
1992-11-12 |
1995-05-04 |
Hybritech Inc |
Altered affinity polypeptides of metal chelate binding antibodies
|
|
US5750349A
(en)
|
1993-01-25 |
1998-05-12 |
Takeda Chemical Industries Ltd. |
Antibodies to β-amyloids or their derivatives and use thereof
|
|
US5955317A
(en)
|
1993-01-25 |
1999-09-21 |
Takeda Chemical Industries, Ltd. |
Antibodies to β-amyloids or their derivatives and use thereof
|
|
CA2115900A1
(en)
|
1993-02-22 |
1994-08-23 |
Gerald W. Becker |
Pharmaceutical screens and antibodies
|
|
WO1995014041A1
(en)
|
1993-11-19 |
1995-05-26 |
Chugai Seiyaku Kabushiki Kaisha |
Reconstituted human antibody against human medulloblastomatous cell
|
|
US5626332A
(en)
|
1994-07-29 |
1997-05-06 |
Harris Corporation |
Vibration isolation system using plural signals for control
|
|
AU702436B2
(en)
|
1994-10-21 |
1999-02-18 |
Innogenetics N.V. |
New sequences of hepatitis C virus genotypes and their use as prophylactic, therapeutic and diagnostic agents
|
|
US6114133A
(en)
|
1994-11-14 |
2000-09-05 |
Elan Pharmaceuticals, Inc. |
Methods for aiding in the diagnosis of Alzheimer's disease by measuring amyloid-β peptide (x-≧41)
|
|
US5589154A
(en)
|
1994-11-22 |
1996-12-31 |
Rutgers, The State University Of New Jersey |
Methods for the prevention or treatment of vascular hemorrhaging and Alzheimer's disease
|
|
US5688651A
(en)
|
1994-12-16 |
1997-11-18 |
Ramot University Authority For Applied Research And Development Ltd. |
Prevention of protein aggregation
|
|
US5786180A
(en)
|
1995-02-14 |
1998-07-28 |
Bayer Corporation |
Monoclonal antibody 369.2B specific for β A4 peptide
|
|
US5756662A
(en)
|
1995-03-14 |
1998-05-26 |
Corixa Corporation |
Compounds and methods for the detection of T. cruzi infection
|
|
US6303567B1
(en)
|
1995-03-14 |
2001-10-16 |
Praecis Pharmaceuticals, Inc . |
Modulators of β-amyloid peptide aggregation comprising D-amino acids
|
|
WO1996036361A1
(en)
|
1995-05-18 |
1996-11-21 |
The Regents Of The University Of Michigan |
Dna binding antibodies
|
|
US6632976B1
(en)
|
1995-08-29 |
2003-10-14 |
Kirin Beer Kabushiki Kaisha |
Chimeric mice that are produced by microcell mediated chromosome transfer and that retain a human antibody gene
|
|
US5846533A
(en)
|
1995-09-14 |
1998-12-08 |
The Regents Of The University Of California |
Antibodies specific for native PrPSc
|
|
JPH09178743A
(ja)
|
1995-12-27 |
1997-07-11 |
Oriental Yeast Co Ltd |
可溶性appの定量法
|
|
NZ334124A
(en)
*
|
1996-08-13 |
2000-10-27 |
P |
Use of the chelating agent clioquinol, with vitamin B12 for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease
|
|
US20030068316A1
(en)
|
1997-02-05 |
2003-04-10 |
Klein William L. |
Anti-ADDL antibodies and uses thereof
|
|
US6218506B1
(en)
|
1997-02-05 |
2001-04-17 |
Northwestern University |
Amyloid β protein (globular assembly and uses thereof)
|
|
US20020086847A1
(en)
|
1997-04-09 |
2002-07-04 |
Mindset Biopharmaceuticals (Usa) |
Recombinant antibodies specific for beta-amyloid ends, DNA encoding and methods of use thereof
|
|
IT1293511B1
(it)
|
1997-07-30 |
1999-03-01 |
Gentili Ist Spa |
Anticorpi monoclonali catalitici ad attivita' proteasica per la lisi selettiva della componente proteica di placche e aggregati correlati
|
|
CA2304505A1
(en)
|
1997-09-24 |
1999-04-01 |
Nova Molecular, Inc. |
Methods for increasing apoe levels for the treatment of neurodegenerative disease
|
|
US7964192B1
(en)
*
|
1997-12-02 |
2011-06-21 |
Janssen Alzheimer Immunotherapy |
Prevention and treatment of amyloidgenic disease
|
|
US6787523B1
(en)
|
1997-12-02 |
2004-09-07 |
Neuralab Limited |
Prevention and treatment of amyloidogenic disease
|
|
TWI239847B
(en)
|
1997-12-02 |
2005-09-21 |
Elan Pharm Inc |
N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
|
|
US7179892B2
(en)
|
2000-12-06 |
2007-02-20 |
Neuralab Limited |
Humanized antibodies that recognize beta amyloid peptide
|
|
US6761888B1
(en)
|
2000-05-26 |
2004-07-13 |
Neuralab Limited |
Passive immunization treatment of Alzheimer's disease
|
|
US6743427B1
(en)
|
1997-12-02 |
2004-06-01 |
Neuralab Limited |
Prevention and treatment of amyloidogenic disease
|
|
US6913745B1
(en)
|
1997-12-02 |
2005-07-05 |
Neuralab Limited |
Passive immunization of Alzheimer's disease
|
|
US6750324B1
(en)
|
1997-12-02 |
2004-06-15 |
Neuralab Limited |
Humanized and chimeric N-terminal amyloid beta-antibodies
|
|
EP1071700B1
(en)
|
1998-04-20 |
2010-02-17 |
GlycArt Biotechnology AG |
Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity
|
|
DE69920897T2
(de)
|
1998-04-28 |
2005-10-13 |
Smithkline Beecham Corp. |
Monoklonale antikörper mit verringerter immunisierungsfähigkeit
|
|
US20030147882A1
(en)
|
1998-05-21 |
2003-08-07 |
Alan Solomon |
Methods for amyloid removal using anti-amyloid antibodies
|
|
US7083950B2
(en)
|
1998-09-25 |
2006-08-01 |
Regeneron Pharmaceuticals, Inc. |
High affinity fusion proteins and therapeutic and diagnostic methods for use
|
|
US6737056B1
(en)
|
1999-01-15 |
2004-05-18 |
Genentech, Inc. |
Polypeptide variants with altered effector function
|
|
HUP0104865A3
(en)
|
1999-01-15 |
2004-07-28 |
Genentech Inc |
Polypeptide variants with altered effector function
|
|
US6998124B1
(en)
|
1999-04-14 |
2006-02-14 |
Smithkline Beecham Corporation |
Erythropoietin receptor antibodies
|
|
US6787637B1
(en)
|
1999-05-28 |
2004-09-07 |
Neuralab Limited |
N-Terminal amyloid-β antibodies
|
|
DK1409654T3
(da)
|
1999-06-16 |
2008-12-08 |
Boston Biomedical Res Inst |
Immunologisk styring af beta-amyloid-niveauer in vivo
|
|
ES2344189T3
(es)
|
1999-09-03 |
2010-08-20 |
RAMOT UNIVERSITY AUTHORITY FOR APPLIED RESEARCH & INDUSTRIAL DEVELOPMENT LTD. |
Agentes, composiciones y metodos que los utilizan utiles en el tratamiento o la prevencion de la enfermedad de alzheimer.
|
|
US20040013647A1
(en)
|
1999-09-03 |
2004-01-22 |
Ramot At Tel-Aviv University Ltd. |
Methods and compositions for treating a plaque-forming disease
|
|
US6294171B2
(en)
|
1999-09-14 |
2001-09-25 |
Milkhaus Laboratory, Inc. |
Methods for treating disease states comprising administration of low levels of antibodies
|
|
BR0016022A
(pt)
|
1999-11-29 |
2002-08-06 |
Neurochem Inc |
Vacina para a prevenção e tratamento da doença de alzheimer e doenças relacionadas ao amilóide
|
|
US20020094335A1
(en)
|
1999-11-29 |
2002-07-18 |
Robert Chalifour |
Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases
|
|
RU2156929C1
(ru)
*
|
1999-12-28 |
2000-09-27 |
Панин Александр Андреевич |
Воздушная холодильная установка, турбодетандер-электрокомпрессор воздушной холодильной установки и турбинное колесо турбодетандера
|
|
US20020182660A1
(en)
|
2000-02-18 |
2002-12-05 |
Fong Kei-Lai L. |
N- and C-terminus specific immunoassays for full length beta-amyloid peptide-Abeta(1-40), Abeta(1-39), Abeta(1-40), Abeta(1-42) , and Abeta(1-43)
|
|
CA2400559C
(en)
*
|
2000-02-24 |
2012-05-01 |
Washington University |
Humanized antibodies that sequester .alpha..beta. peptide
|
|
EP1130032A1
(en)
|
2000-02-28 |
2001-09-05 |
Gesellschaft für biotechnologische Forschung mbH (GBF) |
Single-chain antibodies recognizing the human vascular endothelial growth factor receptor-2 (VEGFR-2/KDR)
|
|
WO2001075165A2
(en)
|
2000-03-30 |
2001-10-11 |
Elan Pharmaceuticals, Inc. |
Screening markers and methods for neurodegenerative disorders
|
|
US7371365B2
(en)
|
2000-04-04 |
2008-05-13 |
Mayo Foundation For Medical Education And Research |
Methods for detecting parenchymal plaques in vivo
|
|
US20020009445A1
(en)
|
2000-07-12 |
2002-01-24 |
Yansheng Du |
Human beta-amyloid antibody and use thereof for treatment of alzheimer's disease
|
|
US6514221B2
(en)
|
2000-07-27 |
2003-02-04 |
Brigham And Women's Hospital, Inc. |
Blood-brain barrier opening
|
|
CN1468250A
(zh)
|
2000-08-03 |
2004-01-14 |
��ķһ����˹��̹ |
在转基因动物中产生人源化抗体
|
|
US6750210B2
(en)
|
2000-08-05 |
2004-06-15 |
Smithkline Beecham Corporation |
Formulation containing novel anti-inflammatory androstane derivative
|
|
AU2001286930A1
(en)
|
2000-08-30 |
2002-03-13 |
The Board Of Trustees Of The Leland Stanford Junior University |
Glucocorticoid blocking agents for increasing blood-brain barrier permeability
|
|
EP2067863A3
(en)
|
2000-09-06 |
2013-11-06 |
Aventis Pharma S.A. |
Methods and compositions for diseases associated with amyloidosis
|
|
US7034036B2
(en)
|
2000-10-30 |
2006-04-25 |
Pain Therapeutics, Inc. |
Inhibitors of ABC drug transporters at the blood-brain barrier
|
|
US20030083299A1
(en)
|
2000-11-04 |
2003-05-01 |
Ferguson Ian A. |
Non-invasive delivery of polypeptides through the blood-brain barrier
|
|
TWI255272B
(en)
|
2000-12-06 |
2006-05-21 |
Guriq Basi |
Humanized antibodies that recognize beta amyloid peptide
|
|
US20040191264A1
(en)
|
2001-02-19 |
2004-09-30 |
Nielsen Klaus Gregorius |
Synthetic vaccine agents
|
|
US6815175B2
(en)
|
2001-03-16 |
2004-11-09 |
Cornell Research Foundation, Inc. |
Anti-amyloid peptide antibody based diagnosis and treatment of a neurological disease or disorder
|
|
US7318923B2
(en)
|
2001-04-30 |
2008-01-15 |
Eli Lilly And Company |
Humanized anti-βantibodies
|
|
AU2002257162A1
(en)
|
2001-04-30 |
2002-11-11 |
Eli Lilly And Company |
Humanized antibodies
|
|
DE10121982B4
(de)
|
2001-05-05 |
2008-01-24 |
Lts Lohmann Therapie-Systeme Ag |
Nanopartikel aus Protein mit gekoppeltem Apolipoprotein E zur Überwindung der Blut-Hirn-Schranke und Verfahren zu ihrer Herstellung
|
|
DE50103881D1
(de)
|
2001-06-12 |
2004-11-04 |
Wiltfang Jens |
Monoklonaler Antikörper, mbAb 1E8, welcher für die zwei ersten N-terminalen Aminosäuren von Amyloid-beta-Peptiden spezifisch ist und dessen Verwendung zum Nachweis von Amyloid-beta Peptiden und/oder sAPPa
|
|
US6638722B2
(en)
|
2001-06-13 |
2003-10-28 |
Invitrogen Corporation |
Method for rapid amplification of DNA
|
|
WO2003000714A2
(en)
|
2001-06-22 |
2003-01-03 |
Panacea Pharmaceuticals, Inc. |
Compositions and methods for preventing protein aggregation in neurodegenerative diseases
|
|
CN1396183A
(zh)
|
2001-07-13 |
2003-02-12 |
张小如 |
降低脑内与老年痴呆有关的淀粉样变纤维的融合人抗体
|
|
WO2003009815A2
(en)
|
2001-07-25 |
2003-02-06 |
Biomarin Pharmaceutical Inc. |
Compositions and methods for modulating blood-brain barrier transport
|
|
NZ581474A
(en)
|
2001-08-03 |
2011-04-29 |
Glycart Biotechnology Ag |
Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
|
|
JP4729717B2
(ja)
|
2001-08-03 |
2011-07-20 |
株式会社医学生物学研究所 |
GM1ガングリオシド結合型アミロイドβタンパク質を認識する抗体、及び該抗体をコードするDNA
|
|
EP1519740A4
(en)
*
|
2001-08-17 |
2005-11-09 |
Lilly Co Eli |
FASTER IMPROVEMENT OF COGNITION IN DISEASES ASSOCIATED WITH A-BETA
|
|
US20040192898A1
(en)
|
2001-08-17 |
2004-09-30 |
Jia Audrey Yunhua |
Anti-abeta antibodies
|
|
JP2005500389A
(ja)
|
2001-08-17 |
2005-01-06 |
イーライ・リリー・アンド・カンパニー |
Aβに関連する病態および疾患を治療するための、可溶性Aβに高い親和性を有する抗体の使用
|
|
US7771722B2
(en)
|
2001-08-17 |
2010-08-10 |
Eli Lilly And Company |
Assay method for alzheimer's disease
|
|
US20030082191A1
(en)
|
2001-08-29 |
2003-05-01 |
Poduslo Joseph F. |
Treatment for central nervous system disorders
|
|
GB0124317D0
(en)
|
2001-10-10 |
2001-11-28 |
Celltech R&D Ltd |
Biological products
|
|
EP1448601A4
(en)
|
2001-11-02 |
2006-04-26 |
Diagenics Internat Corp |
METHOD AND COMPOSITIONS OF MONOCLONAL ANTIBODIES SPECIFIC TO BETA-AMYLOIDE PROTEINS
|
|
CA2500462A1
(en)
|
2001-12-26 |
2004-03-25 |
Universidad De Zaragoza |
Polyclonal antibodies, preparation method thereof and use of same
|
|
AR038568A1
(es)
|
2002-02-20 |
2005-01-19 |
Hoffmann La Roche |
Anticuerpos anti-a beta y su uso
|
|
US20030162695A1
(en)
|
2002-02-27 |
2003-08-28 |
Schatzberg Alan F. |
Glucocorticoid blocking agents for increasing blood-brain barrier permeability
|
|
MXPA04008670A
(es)
|
2002-03-07 |
2005-07-13 |
Advisys Inc |
Ensamble de electrodo para electroporacion de corriente constante y uso.
|
|
MY139983A
(en)
|
2002-03-12 |
2009-11-30 |
Janssen Alzheimer Immunotherap |
Humanized antibodies that recognize beta amyloid peptide
|
|
US20030190689A1
(en)
|
2002-04-05 |
2003-10-09 |
Cell Signaling Technology,Inc. |
Molecular profiling of disease and therapeutic response using phospho-specific antibodies
|
|
AU2003226356A1
(en)
|
2002-04-12 |
2003-10-27 |
Ramot At Tel Aviv University Ltd. |
Prevention of brain inflammation as a result of induced autoimmune response
|
|
AU2003218560B2
(en)
|
2002-04-19 |
2009-09-03 |
The Governing Council Of The University Of Toronto |
Immunological methods and compositions for the treatment of alzheimer's disease
|
|
WO2003090772A1
(en)
|
2002-04-25 |
2003-11-06 |
Eli Lilly And Company |
Method for treating anxiety and mood disorders in older subjects
|
|
CA2487528A1
(en)
|
2002-07-24 |
2004-02-12 |
Innogenetics N.V. |
Prevention, treatment and diagnosis of diseases associated with beta-amyloid formation and/or aggregation
|
|
CA2498407A1
(en)
|
2002-09-12 |
2004-03-25 |
The Regents Of The University Of California |
Immunogens and corresponding antibodies specific for high molecular weight aggregation intermediates common to amyloids formed from proteins of differing sequence
|
|
WO2004029629A1
(en)
|
2002-09-27 |
2004-04-08 |
Janssen Pharmaceutica N.V. |
N-11 truncated amyloid-beta nomoclonal antibodies, compositions, methods and uses
|
|
US7541440B2
(en)
|
2002-09-30 |
2009-06-02 |
Immunomedics, Inc. |
Chimeric, human and humanized anti-granulocyte antibodies and methods of use
|
|
US20070213512A1
(en)
|
2002-10-01 |
2007-09-13 |
Krafft Grant A |
Amyloid beta peptide analogs and assemblies thereof
|
|
CA2501091A1
(en)
|
2002-10-01 |
2004-04-15 |
Northwestern University |
Amyloid beta-derived diffusible ligands (addls), addl-surrogates, addl-binding molecules, and uses thereof
|
|
PL377769A1
(pl)
|
2002-10-09 |
2006-02-20 |
Rinat Neuroscience Corp. |
Sposób leczenia choroby Alzheimera z zastosowaniem przeciwciał skierowanych przeciw peptydowi beta amyloidu i ich kompozycje
|
|
DE10256900A1
(de)
|
2002-11-29 |
2004-06-24 |
Nemod Immuntherapie Ag |
Tumorspezifische Erkennungsmoleküle
|
|
CA2507762C
(en)
|
2002-12-03 |
2013-02-05 |
Blanchette Rockefeller Neurosciences Institute |
Artificial low-density lipoprotein carriers for transport of substances across the blood-brain barrier
|
|
WO2004056318A2
(en)
|
2002-12-19 |
2004-07-08 |
New York University |
Method for treating amyloid disease
|
|
EP1439192A1
(en)
|
2003-01-15 |
2004-07-21 |
Xerion Pharmaceuticals AG |
Neuropilin-1 inhibitors
|
|
US20050031651A1
(en)
|
2002-12-24 |
2005-02-10 |
Francine Gervais |
Therapeutic formulations for the treatment of beta-amyloid related diseases
|
|
MXPA05006940A
(es)
|
2002-12-24 |
2006-02-22 |
Neurochem Int Ltd |
Formulaciones terapeuticas para el tratamiento de enfermedades relacionadas con beta - amiloide.
|
|
EP2368578A1
(en)
|
2003-01-09 |
2011-09-28 |
Macrogenics, Inc. |
Identification and engineering of antibodies with variant Fc regions and methods of using same
|
|
AT413945B
(de)
|
2003-01-14 |
2006-07-15 |
Mattner Frank Dr |
Impfstoff für die alzheimer-krankheit
|
|
WO2004065569A2
(en)
|
2003-01-23 |
2004-08-05 |
The Regents Of The University Of California |
Multi-functional antibodies
|
|
DE10303974A1
(de)
|
2003-01-31 |
2004-08-05 |
Abbott Gmbh & Co. Kg |
Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
|
|
KR20050118669A
(ko)
|
2003-02-01 |
2005-12-19 |
뉴랄랩 리미티드 |
가용성 a-베타에 대한 항체를 생성하기 위한 능동 면역화
|
|
ATE468886T1
(de)
*
|
2003-02-10 |
2010-06-15 |
Applied Molecular Evolution |
Abeta-bindende moleküle
|
|
US8663650B2
(en)
|
2003-02-21 |
2014-03-04 |
Ac Immune Sa |
Methods and compositions comprising supramolecular constructs
|
|
US20040242845A1
(en)
|
2003-02-21 |
2004-12-02 |
Nicolau Yves Claude |
Methods and compositions comprising supramolecular antigenic constructs and antibodies elicited against them
|
|
KR20060054174A
(ko)
|
2003-03-28 |
2006-05-22 |
센토코 인코포레이티드 |
항-아밀로이드 항체, 조성물, 방법 및 용도
|
|
EP1469312A1
(en)
|
2003-04-18 |
2004-10-20 |
Friedrich-Alexander-Universität Erlangen-Nürnberg |
Diagnosis of Alzheimer's disease
|
|
US20040223912A1
(en)
|
2003-05-07 |
2004-11-11 |
Montalto Michael Christopher |
Compositions and methods for non-invasive imaging of soluble beta-amyloid
|
|
ES2246177B1
(es)
|
2003-05-08 |
2007-03-01 |
Universidad De Zaragoza. |
Uso de anticuerpos para el tratamiento de enfermedades amiloideas.
|
|
EP1480041A1
(en)
|
2003-05-22 |
2004-11-24 |
Innogenetics N.V. |
Method for the prediction, diagnosis and differential diagnosis of Alzheimer's disease
|
|
TWI374893B
(en)
|
2003-05-30 |
2012-10-21 |
Janssen Alzheimer Immunotherap |
Humanized antibodies that recognize beta amyloid peptide
|
|
AU2004294893A1
(en)
|
2003-06-06 |
2005-06-16 |
Oncomax Acquisition Corp. |
Antibodies specific for cancer associated antigen SM5-1 and uses thereof
|
|
US20050124016A1
(en)
|
2003-08-01 |
2005-06-09 |
Enh Research Institute |
Antibodies specific for toxic amyloid beta protein oligomers
|
|
WO2005018424A2
(en)
|
2003-08-18 |
2005-03-03 |
Research Foundation For Mental Hygiene, Inc. |
Antibodies specific for fibrillar amyloid and a procedure to detect fibrillar amyloid deposits
|
|
EP1666061A1
(en)
|
2003-09-09 |
2006-06-07 |
Takeda Pharmaceutical Company Limited |
Use of antibody
|
|
JP2007505142A
(ja)
|
2003-09-10 |
2007-03-08 |
セダーズ−シナイ メディカル センター |
血液脳関門を通過する薬剤のカリウムチャネル媒介性送達
|
|
JP2007527865A
(ja)
|
2003-09-12 |
2007-10-04 |
ザ・レジェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア |
種々の配列を有するタンパク質から形成されたアミロイドに共通の高分子量凝集中間体に特異的なモノクローナル抗体
|
|
US20070015218A1
(en)
|
2003-10-14 |
2007-01-18 |
University Of South Florida |
A Method for the Separation Anti-Amyloid Beta Antibody with Amyloid Beta Peptide
|
|
JP4870348B2
(ja)
|
2003-12-04 |
2012-02-08 |
株式会社ペルセウスプロテオミクス |
細胞表面抗原に対する抗体取得とその抗原同定
|
|
MY144231A
(en)
|
2003-12-17 |
2011-08-15 |
Wyeth Corp |
Aß IMMUNOGENIC PEPTIDE CARRIER CONJUGATES AND METHODS OF PRODUCING SAME
|
|
WO2005080435A1
(ja)
|
2004-02-20 |
2005-09-01 |
Immuno-Biological Laboratories Co., Ltd. |
モノクローナル抗体およびその利用
|
|
KR20090005410A
(ko)
|
2004-02-23 |
2009-01-13 |
일라이 릴리 앤드 캄파니 |
항-Aβ 항체
|
|
JPWO2005105998A1
(ja)
|
2004-04-27 |
2008-07-31 |
財団法人化学及血清療法研究所 |
ヒト抗アミロイドβペプチド抗体およびその抗体フラグメント
|
|
DE602005022871D1
(de)
|
2004-06-07 |
2010-09-23 |
Univ Ramot |
Verfahren zur passiven immunisierung gegen eine durch amyloidaggregation gekennzeichnete krankheit oder erkrankung mit vermindertem nervenentzündungsrisiko
|
|
SE0401601D0
(sv)
|
2004-06-21 |
2004-06-21 |
Bioarctic Neuroscience Ab |
Protofibril specific antibodies and uses thereof
|
|
CA2572602A1
(en)
|
2004-07-02 |
2006-02-09 |
Northwestern University |
Monolocal antibodies that target pathological assemblies of amyloid .beta. (abeta)
|
|
US20090156471A1
(en)
|
2004-07-15 |
2009-06-18 |
Ramot At Tel Aviv University Ltd. |
Use of anti-amyloid agents for treating and typing pathogen infections
|
|
CA2575663C
(en)
|
2004-07-30 |
2013-04-23 |
Rinat Neuroscience Corp. |
Antibodies directed against amyloid-beta peptide and methods using same
|
|
WO2006016644A1
(ja)
|
2004-08-11 |
2006-02-16 |
Mitsubishi Chemical Corporation |
抗体及びその利用
|
|
TWI374935B
(en)
|
2004-08-27 |
2012-10-21 |
Pfizer Ireland Pharmaceuticals |
Production of α-abeta
|
|
TWI380996B
(zh)
|
2004-09-17 |
2013-01-01 |
Hoffmann La Roche |
抗ox40l抗體
|
|
WO2006039470A2
(en)
|
2004-09-29 |
2006-04-13 |
Centocor, Inc. |
Anti- amyloid antibodies, compositions, methods and uses
|
|
DE602005026219D1
(de)
|
2004-10-01 |
2011-03-17 |
Max Planck Gesellschaft |
Gegen das säugetier-eag1-ionenkanalprotein gerichtete antikörper
|
|
WO2006039327A2
(en)
|
2004-10-01 |
2006-04-13 |
Merck & Co., Inc. |
Methods of treatment or prophylaxis of amyloidogenic diseases of the eye or optic nerve
|
|
BRPI0518151A2
(pt)
|
2004-10-13 |
2009-06-16 |
Ablynx Nv |
polipetìdeos contra amiloide-beta, ácido nucléico que codifica tal polipetìdeo, composição compreendendo tal polipetìdeo, método para produzir um polipetìdeo e uso do mesmo
|
|
BRPI0516962A
(pt)
|
2004-10-25 |
2008-09-30 |
Univ Northwestern |
anticorpo isolado, ou fragmento do mesmo, composição farmacêutica, métodos para prevenir a ligação de ligantes difundìveis derivados de abeta a um neurÈnio, para inibir a constituição de ligantes difundìveis, para bloquear a fosforilação de proteìna, para tratar profilaticamente ou terapeuticamente uma doença, para identificar um agente terapêutico, para detectar ligantes difundìveis, e para diagnosticar uma doença, e, kit para detectar ligantes difundìveis
|
|
WO2006047670A2
(en)
|
2004-10-26 |
2006-05-04 |
Wyeth |
Methods for assessing antibodies to neurodegenerative disease-associated antigens
|
|
WO2006046644A1
(ja)
|
2004-10-28 |
2006-05-04 |
Sanko Junyaku Co., Ltd. |
アルツハイマー病の検定方法及び診断試薬
|
|
AR052051A1
(es)
|
2004-12-15 |
2007-02-28 |
Neuralab Ltd |
Anticuerpos ab humanizados usados en mejorar la cognicion
|
|
PE20061401A1
(es)
*
|
2004-12-15 |
2006-12-23 |
Neuralab Ltd |
ANTICUERPOS Aß PARA MEJORAR LA COGNICION
|
|
TW200636066A
(en)
|
2004-12-15 |
2006-10-16 |
Elan Pharm Inc |
Humanized antibodies that recognize beta amyloid peptide
|
|
EP1827493A4
(en)
|
2004-12-22 |
2009-09-30 |
Univ St Louis |
USE OF ANTI-ABETA ANTIBODIES FOR THE TREATMENT OF BRAIN TRAUMA
|
|
EP1841455A1
(en)
|
2005-01-24 |
2007-10-10 |
Amgen Inc. |
Humanized anti-amyloid antibody
|
|
GT200600031A
(es)
|
2005-01-28 |
2006-08-29 |
|
Formulacion anticuerpo anti a beta
|
|
WO2006094724A2
(en)
|
2005-03-05 |
2006-09-14 |
Abbott Gmbh & Co. Kg |
Screening method, process for purifying of non-diffusible a-beta oligomers, selective antibodies against said non-diffusible a-beta oligomers and a process for manufacturing of said antibodies
|
|
ES2259270B1
(es)
|
2005-03-09 |
2007-11-01 |
Consejo Superior De Investigaciones Cientificas |
Metodo de diagnostico in vitro de la enfermedad de alzheimer mediante un anticuerpo monoclonal.
|
|
PE20061323A1
(es)
|
2005-04-29 |
2007-02-09 |
Rinat Neuroscience Corp |
Anticuerpos dirigidos contra el peptido amiloide beta y metodos que utilizan los mismos
|
|
MY144484A
(en)
|
2005-06-17 |
2011-09-30 |
Wyeth Corp |
Methods of purifying anti a beta antibodies
|
|
JP2007077103A
(ja)
|
2005-09-16 |
2007-03-29 |
Yokohama City Univ |
アルツハイマー病の予防又は治療剤
|
|
KR101667623B1
(ko)
|
2005-11-30 |
2016-10-19 |
애브비 인코포레이티드 |
아밀로이드 베타 단백질에 대한 모노클로날 항체 및 이의 용도
|
|
CA2637472A1
(en)
|
2005-11-30 |
2007-06-07 |
Abbott Laboratories |
Methods of preparation of recombinant forms of human beta-amyloid protein and uses of these proteins
|
|
EP2289909B1
(en)
|
2005-11-30 |
2014-10-29 |
AbbVie Inc. |
Screening method, process for purifying of non-diffusible a-beta oligomers, selective antibodies against said non-diffusible a-beta oligomers and a process for manufacturing of said antibodies
|
|
EP1973951A2
(en)
|
2005-12-02 |
2008-10-01 |
Genentech, Inc. |
Binding polypeptides with restricted diversity sequences
|
|
RS53291B
(sr)
|
2005-12-12 |
2014-08-29 |
Ac Immune S.A. |
Beta 1-42 specifična monoklonska antitela sa terapeutskim svojstvima
|
|
DK1979001T3
(da)
|
2005-12-13 |
2012-07-16 |
Medimmune Ltd |
Bindingsproteiner, der er specifikke for insulinlignende vækstfaktorer og anvendelser deraf
|
|
CN103539857A
(zh)
|
2006-03-30 |
2014-01-29 |
葛兰素集团有限公司 |
针对β-淀粉样蛋白肽的抗体
|
|
US7427342B2
(en)
|
2006-06-02 |
2008-09-23 |
General Electric Company |
Method and apparatus for shifting current distribution in electrodeionization systems
|
|
CL2007002070A1
(es)
|
2006-07-14 |
2008-02-08 |
Ac Immune S A Genentech Inc |
Anticuerpo quimerico o humanizado, o fragmentos de ellos, que se adhieren especificamente a por lo menos un epitopo en la proteina beta-amiloide; molecula de acido nucleico que lo codifica; composicion que lo comprende; su uso para tratar enfermedade
|
|
WO2008008463A2
(en)
|
2006-07-14 |
2008-01-17 |
Trustees Of Columbia University In The City Of New York |
METHODS AND COMPOSITIONS FOR DETECTING AND QUANTIFYING SAPPβ
|
|
BRPI0719763A2
(pt)
|
2006-10-02 |
2014-01-28 |
Ac Immune Sa |
Anticorpo, molécula de ácido nucleico, vetor de expressão, célula, composição, mistura, uso de um anticorpo quimérico ou um fragmento do mesmo ou um anticorpo humanizado ou um fragmento do mesmo e/ou uma parte funcional e/ou uma composição farmacêutica ou uma mistura, métodos para a preparação de uma composição farmacêutica ou de uma mistura, para prevenir, tratar ou aliviar os efeitos de uma doença, de diagnóstico de uma doença ou condição associada com amilóide em um paciente e de determinação do grau da carga de placa amiloidogênica em um tecido e/ou fluidos corporais, kits de teste para a detecção e diagnóstico de doenças e condições associadas com amilóide, região variável de cadeia leve, região variável de cadeia pesada, linhagem de célula, gene de anticorpo, e, métodos para desagregar fibras de beta-amilóide pré formadas, para prevenir a degradação de neurônio induzida por abeta, para diagnosticar uma predisposição a uma doença ou condição associada com amilóide em um paciente, para monitorar doença residual mínima em um paciente, para prognosticar a responsividade de um paciente que é tratado com um anticorpo ou uma composição de vacina, para reduzir a carga de placa no cérebro de um animal, para reduzir a quantidade de placas no cérebro de um animal, para diminuir a quantidade total de abeta solúvel no cérebro de um animal e para reter ou aumentar a capacidade de memória cognitiva em um mamífero.
|
|
AU2007324696B2
(en)
|
2006-11-24 |
2012-10-04 |
Ac Immune S.A. |
N- (methyl) -1H- pyrazol- 3 -amine, N- (methyl) -pyridin-2-amine and N- (methyl) -thiazol-2-amine derivatives for the treatment of diseases associated with amyloid or amyloid-like proteins, like e.g. Alzheimer's
|
|
JP2008135645A
(ja)
|
2006-11-29 |
2008-06-12 |
Toshiba Corp |
多層プリント配線板および多層プリント配線板の層間接合方法
|
|
US8455626B2
(en)
|
2006-11-30 |
2013-06-04 |
Abbott Laboratories |
Aβ conformer selective anti-aβ globulomer monoclonal antibodies
|
|
US20090022728A1
(en)
|
2007-03-09 |
2009-01-22 |
Rinat Neuroscience Corporation |
Methods of treating ophthalmic diseases
|
|
US20090175847A1
(en)
|
2007-05-30 |
2009-07-09 |
Abbott Laboratories |
Humanized antibodies to ab (20-42) globulomer and uses thereof
|
|
US20090232801A1
(en)
|
2007-05-30 |
2009-09-17 |
Abbot Laboratories |
Humanized Antibodies Which Bind To AB (1-42) Globulomer And Uses Thereof
|
|
AR066987A1
(es)
|
2007-06-12 |
2009-09-23 |
Ac Immune Sa |
Anticuerpo monoclonal contra proteina beta-amiloide
|
|
US8613923B2
(en)
|
2007-06-12 |
2013-12-24 |
Ac Immune S.A. |
Monoclonal antibody
|
|
US8048420B2
(en)
|
2007-06-12 |
2011-11-01 |
Ac Immune S.A. |
Monoclonal antibody
|
|
TW201518320A
(zh)
|
2007-06-12 |
2015-05-16 |
Ac Immune Sa |
特異性結合β-類澱粉蛋白之抗體及相關核酸分子、表現載體、細胞、組合物、套組、方法及用途
|
|
AU2008311366B2
(en)
|
2007-10-05 |
2015-03-12 |
Ac Immune S.A. |
Use of anti-amyloid beta antibody in ocular diseases
|
|
SG185277A1
(en)
|
2007-10-05 |
2012-11-29 |
Genentech Inc |
Humanized antibody
|
|
AU2008311367B2
(en)
|
2007-10-05 |
2014-11-13 |
Ac Immune S.A. |
Use of anti-amyloid beta antibody in ocular diseases
|
|
JO3076B1
(ar)
|
2007-10-17 |
2017-03-15 |
Janssen Alzheimer Immunotherap |
نظم العلاج المناعي المعتمد على حالة apoe
|
|
CA2806909C
(en)
|
2010-07-30 |
2019-12-17 |
Ac Immune S.A. |
Safe and functional humanized antibodies
|